Home
News
Screeners
Insights
Elixir Capital
100.
00
-1.27
(-1.25%)
Market Cap
₹58.16 Cr
PE Ratio
6.75
Industry
Financial Services
Buy
Sell
Company Performance:
1D
-1.25%
1M
-5.30%
6M
+7.47%
1Y
-9.54%
5Y
0.00%
View Company Insights
Latest news about Elixir Capital
Elixir Capital appoints M. Parashar & Co as statutory auditor
Aug 25, 2026
Elixir Capital shareholders approved FY26 results and a ₹1.25 per share final dividend. M/s. M. Parashar & Co. appointed as statutory auditors for a five-year term till the 37th AGM. Promoter group holding 41,37,000 shares voted unanimously in favour of all resolutions. Total votes polled stood at 41,41,531, representing 71.25% of outstanding shares.
Elixir Capital sets Aug 25 AGM for auditor, director votes
Aug 04, 2026
Elixir Capital fixes record date for dividend and AGM
Jul 18, 2026
Elixir Capital FY26 net profit rises 13.5% to ₹72.44 lakh
May 30, 2026
Elixir Capital Files Newspaper Advertisement for Special Window and Investor Campaign
Apr 07, 2026
More news about Elixir Capital
04
Apr 26
Sandu Pharmaceuticals Publishes Second 100-Day Campaign Notice for KYC Updates
Sandu Pharmaceuticals Limited has published a newspaper notice regarding the Second 100-Day Campaign 'Saksham Niveshak' for KYC updates and shareholder engagement, following SEBI guidelines. The campaign runs from April 1 to July 9, 2026, with MUFG Intime India Private Limited serving as the Registrar and Transfer Agent to facilitate the process.
20
Mar 26
Elixir Capital Subsidiary Faces SEBI Settlement Order Under Algo Platform Scheme
Elixir Capital Limited disclosed that its subsidiary Elixir Equities Private Limited is subject to a SEBI settlement order under the 'Settlement Scheme for Association with Certain Algo Platforms, 2025'. The scheme affects 111 stock brokers, requiring each to pay ₹1,00,000 for alleged violations related to algorithmic trading platforms. The company clarified that the order does not directly impact the listed entity and will not materially affect financial position or operations beyond the settlement amount.
03
Feb 26
Elixir Capital Ltd. schedules board meeting for February 13, 2026 to consider Q3FY26 unaudited financial results
Elixir Capital Ltd. has scheduled a board meeting for February 13, 2026, at 4:00 p.m. to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2025. The company has closed its trading window from January 1, 2026, which will reopen 48 hours after the financial results declaration. This announcement was made in compliance with SEBI (LODR) Regulations, 2015, and communicated to BSE Limited where the company is listed under scrip code 531278.
Elixir Capital
100.
00
-
1.
27
(-
1.
25
%)
1 Year Returns:
-9.54%
Industry Peers
OnEMI Technology Solutions
328.70
(-
1.
56
%)
Spice Lounge Food Works
32.94
(+
4.
97
%)
Algoquant Fintech
64.61
(+
1.
05
%)
Gyftr
175.73
(-
5.
17
%)
Prime Securities
283.05
(+
2.
28
%)
Wealth First Portfolio Managers
845.25
(+
0.
71
%)
RNFI Services
340.00
(+
0.
34
%)
Stellant Securities
1,009.95
(-
0.
49
%)
Kalind
5.78
(-
4.
15
%)
Investment Trust of India
96.80
(-
0.
55
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO
Cyclical Trend
Events Calendar